China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)
000999.SZ Stock Price Chart
Explore China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 000999.SZ price movements and trends.
000999.SZ Company Profile
Discover essential business fundamentals and corporate details for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
9 Mar 2000
Employees
20.03K
Website
https://www.999.com.cnCEO
Wen Duo Wu
Description
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.
000999.SZ Financial Timeline
Browse a chronological timeline of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 16 Aug 2025
EPS came in at ¥0.33 falling short of the estimated ¥0.56 by -41.53%, while revenue for the quarter reached ¥7.96B , beating expectations by +2.41%.
Dividend declared on 6 Jun 2025
A dividend of ¥0.32 per share was announced, adjusted to ¥0.32. The dividend was paid on 6 Jun 2025.
Earnings released on 28 Apr 2025
EPS came in at ¥0.99 surpassing the estimated ¥0.60 by +65.00%, while revenue for the quarter reached ¥6.85B , missing expectations by -9.61%.
Earnings released on 10 Feb 2025
EPS came in at ¥0.31 falling short of the estimated ¥0.32 by -3.13%, while revenue for the quarter reached ¥7.88B , beating expectations by +5.10%.
Dividend declared on 29 Nov 2024
A dividend of ¥1.00 per share was announced, adjusted to ¥1.00. The dividend was paid on 29 Nov 2024.
Earnings released on 26 Oct 2024
EPS came in at ¥0.45 falling short of the estimated ¥0.60 by -25.00%, while revenue for the quarter reached ¥5.63B , missing expectations by -14.13%.
Earnings released on 23 Aug 2024
EPS came in at ¥0.80 surpassing the estimated ¥0.78 by +2.56%, while revenue for the quarter reached ¥6.74B , missing expectations by -3.61%.
Dividend declared on 14 Jun 2024
A dividend of ¥1.50 per share was announced, adjusted to ¥1.50. The dividend was paid on 14 Jun 2024.
Stock split effective on 14 Jun 2024
Shares were split 13 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 20 Apr 2024
EPS came in at ¥1.39 surpassing the estimated ¥0.84 by +65.48%, while revenue for the quarter reached ¥7.22B , beating expectations by +13.83%.
Earnings released on 23 Mar 2024
EPS came in at ¥0.46 matching the estimated ¥0.46, while revenue for the quarter reached ¥6.05B , missing expectations by -23.46%.
Earnings released on 27 Oct 2023
EPS came in at ¥0.54 falling short of the estimated ¥0.72 by -25.00%, while revenue for the quarter reached ¥5.46B , missing expectations by -25.71%.
Earnings released on 30 Aug 2023
EPS came in at ¥0.75 matching the estimated ¥0.75, while revenue for the quarter reached ¥6.79B , missing expectations by -13.58%.
Dividend declared on 15 Jun 2023
A dividend of ¥1.00 per share was announced, adjusted to ¥0.77. The dividend was paid on 15 Jun 2023.
Earnings released on 29 Apr 2023
EPS came in at ¥1.17 surpassing the estimated ¥0.78 by +50.00%, while revenue for the quarter reached ¥6.35B , beating expectations by +60.49%.
Earnings released on 12 Mar 2023
EPS came in at ¥0.49 surpassing the estimated ¥0.45 by +8.89%, while revenue for the quarter reached ¥5.97B , beating expectations by +6.31%.
Earnings released on 28 Oct 2022
EPS came in at ¥0.53 falling short of the estimated ¥0.56 by -5.36%, while revenue for the quarter reached ¥3.71B , missing expectations by -18.99%.
Earnings released on 24 Aug 2022
EPS came in at ¥0.60 falling short of the estimated ¥0.66 by -9.09%, while revenue for the quarter reached ¥4.21B , missing expectations by -0.49%.
Dividend declared on 12 Aug 2022
A dividend of ¥0.85 per share was announced, adjusted to ¥0.66. The dividend was paid on 12 Aug 2022.
Earnings released on 22 Apr 2022
EPS came in at ¥0.86 surpassing the estimated ¥0.60 by +43.33%, while revenue for the quarter reached ¥4.19B , missing expectations by -40.78%.
Earnings released on 11 Mar 2022
EPS came in at ¥0.31 surpassing the estimated ¥0.28 by +10.71%, while revenue for the quarter reached ¥4.22B , missing expectations by -27.36%.
Earnings released on 26 Oct 2021
EPS came in at ¥0.38 falling short of the estimated ¥0.56 by -32.14%, while revenue for the quarter reached ¥3.34B , missing expectations by -32.14%.
Earnings released on 24 Aug 2021
EPS came in at ¥0.74 surpassing the estimated ¥0.52 by +42.31%, while revenue for the quarter reached ¥3.68B .
Dividend declared on 9 Jul 2021
A dividend of ¥0.50 per share was announced, adjusted to ¥0.38. The dividend was paid on 9 Jul 2021.
Earnings released on 30 Apr 2021
EPS came in at ¥0.66 surpassing the estimated ¥0.49 by +34.69%, while revenue for the quarter reached ¥4.08B .
Earnings released on 19 Mar 2021
EPS came in at ¥0.03 falling short of the estimated ¥0.20 by -85.00%, while revenue for the quarter reached ¥4.40B .
Earnings released on 30 Oct 2020
EPS came in at ¥0.51 surpassing the estimated ¥0.32 by +59.38%, while revenue for the quarter reached ¥3.41B .
000999.SZ Stock Performance
Access detailed 000999.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.